Syneos Health, Inc.
SYNH · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $5,393,082 | $5,212,970 | $4,415,777 | $4,675,815 |
| % Growth | 3.5% | 18.1% | -5.6% | – |
| Cost of Goods Sold | $4,138,816 | $3,994,484 | $3,398,142 | $3,645,905 |
| Gross Profit | $1,254,266 | $1,218,486 | $1,017,635 | $1,029,910 |
| % Margin | 23.3% | 23.4% | 23% | 22% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $547,254 | $570,765 | $442,484 | $446,281 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $247,179 | $235,625 | $222,352 | $242,465 |
| Operating Expenses | $794,433 | $806,390 | $664,836 | $688,746 |
| Operating Income | $403,192 | $389,280 | $293,143 | $324,544 |
| % Margin | 7.5% | 7.5% | 6.6% | 6.9% |
| Other Income/Exp. Net | -$88,627 | -$74,120 | -$89,485 | -$136,045 |
| Pre-Tax Income | $314,565 | $315,160 | $203,658 | $101,709 |
| Tax Expense | $48,068 | $80,329 | $10,871 | -$29,549 |
| Net Income | $266,497 | $234,831 | $192,787 | $131,258 |
| % Margin | 4.9% | 4.5% | 4.4% | 2.8% |
| EPS | 2.57 | 2.26 | 1.85 | 1.27 |
| % Growth | 13.7% | 22.2% | 45.7% | – |
| EPS Diluted | 2.54 | 2.24 | 1.83 | 1.25 |
| Weighted Avg Shares Out | 102,974 | 103,872 | 104,168 | 103,618 |
| Weighted Avg Shares Out Dil | 103,477 | 105,065 | 105,465 | 105,005 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,609 | $111 | $265 | $7,542 |
| Interest Expense | $80,788 | $79,141 | $90,880 | $129,820 |
| Depreciation & Amortization | $296,798 | $267,074 | $284,984 | $242,465 |
| EBITDA | $699,990 | $656,354 | $578,127 | $567,009 |
| % Margin | 13% | 12.6% | 13.1% | 12.1% |